AbFinder Therapeutics Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- (In Progress)
- Investors
-
4
AbFinder Therapeutics General Information
Description
Developer of biopharmaceutical discovery platforms intended to focus on replacing peptide and antibody engineering technologies. The company operates an integrated antibody discovery and engineering platform, designed to streamline and optimize the creation of next-generation biologic drugs, and collaborates with biopharmaceutical and biotechnology partners through open innovation models, enabling medical professionals to accelerate therapeutic pipeline development and enhance the performance and differentiation of antibody-based therapies.
Contact Information
Website
www.abfindertrx.comCorporate Office
- Room 730, 7th Floor, LDC Biz Tower
- 47 Heungan-daero 427beon-gil, Dongan-gu
- Anyang, Gyeonggi 14059
- South Korea
Corporate Office
- Room 730, 7th Floor, LDC Biz Tower
- 47 Heungan-daero 427beon-gil, Dongan-gu
- Anyang, Gyeonggi 14059
- South Korea
AbFinder Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 09-Jul-2026 | In Progress | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 28-Oct-2025 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 30-Sep-2025 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 30-Jun-2025 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 09-Jun-2025 | Completed | Pre-Clinical Trials | |||
| 1. Accelerator/Incubator | 02-Jun-2025 | Completed | Pre-Clinical Trials |
AbFinder Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AbFinder Therapeutics Patents
AbFinder Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026095652-A1 | Short peptide having ph-selective binding ability to fcrn | Pending | 31-Oct-2024 |
AbFinder Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AbFinder Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Tech Incubator Program for Startup | Accelerator/Incubator | |||
| BiiG WAVE | Accelerator/Incubator | |||
| Innocube | Accelerator/Incubator | Minority | ||
| WOW Partners | Venture Capital | Minority |
AbFinder Therapeutics FAQs
-
When was AbFinder Therapeutics founded?
AbFinder Therapeutics was founded in 2024.
-
Where is AbFinder Therapeutics headquartered?
AbFinder Therapeutics is headquartered in Anyang, South Korea.
-
What is the size of AbFinder Therapeutics?
AbFinder Therapeutics has 5 total employees.
-
What industry is AbFinder Therapeutics in?
AbFinder Therapeutics’s primary industry is Biotechnology.
-
Is AbFinder Therapeutics a private or public company?
AbFinder Therapeutics is a Private company.
-
What is AbFinder Therapeutics’s current revenue?
The current revenue for AbFinder Therapeutics is .
-
Who are AbFinder Therapeutics’s investors?
Tech Incubator Program for Startup, BiiG WAVE, Innocube, and WOW Partners have invested in AbFinder Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
